環球智能控股(00395.HK)擬出售智能創力51%股權 繼續停牌
格隆匯12月3日丨環球智能控股(00395.HK)發佈公吿,公司全資附屬公司Forever Triumph與買方Casa Mia Caterers International Limited訂立買賣協議,據此,Forever Triumph同意出售目標公司(即智能創力有限公司)的51%股權。
根據買賣協議,Forever Triumph同意出售而買方同意按代價1.00港元收購銷售股份。目標公司於2018年在香港註冊成立的公司。緊接買賣協議日期前,目標公司分別由Forever Triumph及Nutronic Biomedical Group Limited(華康生物醫學(08622.HK)的全資附屬公司)擁有51%及49%權益。目標公司主要從事銷售、營銷及分銷華康生物醫學控股有限公司一間附屬公司所供應的若干產品系列,包括但不限於男女性生育補充品。
應公司要求,公司股份已自2021年4月1日起於聯交所暫停買賣,並將繼續暫停買賣,直至公司符合聯交所有關恢復股份買賣的指引為止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.